News

Hyderabad: Eli Lilly and Company (India) has announced the opening of its new technology and innovation site in Hyderabad; a ...
HYDERABAD: Praising the vision and hard work of IT and Industries Minister D Sridhar Babu, Chief Minister A Revanth Reddy on ...
Hyderabad: Ina major boost to Telangana’s life sciences and innovation ecosystem, global pharmaceutical giant Eli Lilly ...
In a phase 3 trial, the daily GLP-1 pill has shown "meaningful weight loss" and similar side effects to injectable GLP-1 drugs like Ozempic, Eli Lilly has said., Health, Times Now ...
Lupin launches Glucagon for Injection USP in emergency kit, bioequivalent to Eli Lilly's product, with $122M annual sales.
Eli Lilly reports strong Q2 2025 growth, driven by Mounjaro & Zepbound. Highlights include increased guidance, pipeline updates, and key clinical milestones.
Hyderabad: Sales of weight-loss drugs Wegovy by Danish pharmaceutical giant Novo Nordisk and Mounjaro by U.S.-based Eli Lilly ...
While a substantial portion of pipeline assets are externally sourced, many Big Pharmas are tapping into incubators and ...
India's Divi's Laboratories reported first-quarter profit below estimates on Wednesday, as manufacturers producing generic ...
In July 2025 alone, Wegovy clocked Rs 7 crore in sales with around 5,000 injections, while Mounjaro posted Rs 47 crore in ...
As the Official Beverage Partner of L&T Metro Rail (Hyderabad) Ltd (L&TMRHL), the company now has the Exclusive Selling ...
Hyderabad: US-based analytical and clinical laboratory technologies player Agilent Technologies Inc has opened its new ...